Neurocognitive effects of repeated ketamine infusion treatments in patients with treatment resistant depression: a retrospective chart review
Abstract Background Ketamine has emerged as a rapid-acting antidepressant in treatment-resistant depression (TRD) increasingly used in non-research, clinical settings. Few studies, however, have examined neurocognitive effects of repeated racemic ketamine infusion treatments in patients with TRD. In...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-02-01
|
Series: | BMC Psychiatry |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12888-022-03789-3 |